Sanofi [SNY] Revenue clocked in at $44.07 billion, up 8.38% YTD: What’s Next?

Sanofi [NASDAQ: SNY] price plunged by -0.09 percent to reach at -$0.05. The company report on June 30, 2021 that Sanofi: Information concerning the total number of voting rights and shares – May 2021.

>> 7 Top Picks for the Post-Pandemic Economy <<

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority).

Sanofia French société anonyme with a registered share capital of 2,517,943,476 €Registered office : 54, rue La Boétie – 75008 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844.

A sum of 1674345 shares traded at recent session while its average daily volume was at 1.27M shares. Sanofi shares reached a high of $52.78 and dropped to a low of $52.395 until finishing in the latest session at $52.66.

The one-year SNY stock forecast points to a potential upside of 17.56. The average equity rating for SNY stock is currently 1.00, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Sanofi [SNY]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SNY shares is $63.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SNY stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Deutsche Bank have made an estimate for Sanofi shares, keeping their opinion on the stock as Sell, with their previous recommendation back on January 15, 2021. The new note on the price target was released on September 29, 2020, representing the official price target for Sanofi stock.

The Average True Range (ATR) for Sanofi is set at 0.60, with the Price to Sales ratio for SNY stock in the period of the last 12 months amounting to 2.97. The Price to Book ratio for the last quarter was 2.09.

SNY Stock Performance Analysis:

Sanofi [SNY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.11. With this latest performance, SNY shares gained by 0.36% in over the last four-week period, additionally plugging by 9.12% over the last 6 months – not to mention a rise of 3.15% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SNY stock in for the last two-week period is set at 48.95, with the RSI for the last a single of trading hit 46.98, and the three-weeks RSI is set at 50.75 for Sanofi [SNY]. The present Moving Average for the last 50 days of trading for this stock 52.61, while it was recorded at 52.76 for the last single week of trading, and 49.94 for the last 200 days.

Insight into Sanofi Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Sanofi [SNY] shares currently have an operating margin of +20.18 and a Gross Margin at +61.28. Sanofi’s Net Margin is presently recorded at +34.17.

Return on Total Capital for SNY is now 8.46, given the latest momentum, and Return on Invested Capital for the company is 15.04. Return on Equity for this stock inclined to 20.20, with Return on Assets sitting at 10.84. When it comes to the capital structure of this company, Sanofi [SNY] has a Total Debt to Total Equity ratio set at 37.58. Additionally, SNY Total Debt to Total Capital is recorded at 27.31, with Total Debt to Total Assets ending up at 20.67. Long-Term Debt to Equity for the company is recorded at 32.82, with the Long-Term Debt to Total Capital now at 23.85.

Reflecting on the efficiency of the workforce at the company, Sanofi [SNY] managed to generate an average of $123,868 per employee. Receivables Turnover for the company is 3.60 with a Total Asset Turnover recorded at a value of 0.32.

SNY Stock EPS

With the latest financial reports released by the company, Sanofi posted 0.7/share EPS, while the average EPS was predicted by analysts to be reported at 0.65/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 7.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SNY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sanofi go to 7.50%.

Sanofi [SNY] Insider Position Details

There are presently around $10,433 million, or 8.00% of SNY stock, in the hands of institutional investors. The top three institutional holders of SNY stocks are: DODGE & COX with ownership of 69,061,384, which is approximately 72.634% of the company’s market cap and around 16.40% of the total institutional ownership; FISHER ASSET MANAGEMENT, LLC, holding 18,132,625 shares of the stock with an approximate value of $954.86 million in SNY stocks shares; and BLACKROCK INC., currently with $795.08 million in SNY stock with ownership of nearly 9.811% of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in Sanofi stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 267 institutional holders increased their position in Sanofi [NASDAQ:SNY] by around 39,381,055 shares. Additionally, 255 investors decreased positions by around 16,384,187 shares, while 116 investors held positions by with 142,353,322 shares. The mentioned changes placed institutional holdings at 198,118,564 shares, according to the latest SEC report filing. SNY stock had 55 new institutional investments in for a total of 2,631,069 shares, while 76 institutional investors sold positions of 6,722,417 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam